Anticoagulant treatment
<p>Reliability and validity of the Maltese version of the Perception of Anticoagulant Treatment Questionnaire (PACT-Q)</p>
... lant treatment and is administered prior to treatment initiation, while the PACT-Q2 measures the convenience and the satisfaction and is administered during anticoa- gulant ...and Treatment ” ), ...
11
Scoring and psychometric validation of the Perception of Anticoagulant Treatment Questionnaire (PACT-Q©)
... used anticoagulant agents for the secondary pre- vention of venous thromboembolic disease and the prevention of systemic embolism in patients with atrial fibrillation ...bleedings, anticoagulant ...
12
Anticoagulant treatment at a specialized outpatient anticoagulant therapy unit, a descriptive study
... for treatment were ...oral anticoagulant treatment have changed, and the signif- icance of coagulopathies may have been under- or overes- timated in the ...continue treatment despite lack of ...
7
Multinational development of a questionnaire assessing patient satisfaction with anticoagulant treatment: the 'Perception of Anticoagulant Treatment Questionnaire' (PACT-Q©)
... lant Treatment Satisfaction" and "Burden of Disease and Treatment"), and then prioritised according to their rele- vance in assessing treatment satisfaction and convenience as well as on ...
13
Oral anticoagulant treatment in patients with mechanical heart valves: how to reduce the risk of thromboembolic and bleeding complications
... The results showed that when an increased throm- boembolic risk had been established for a subgroup (e.g. mitral versus aortic valve), this was associated with a higher incidence of thro[r] ...
6
Fatal recurrent VTE after anticoagulant treatment for unprovoked VTE: a systematic review
... anticoagulation treatment, eight had fewer than 100 patients, four did not distinguish between provoked and unprovoked VTE and authors did not comply with our data request after at least two attempts, and eight ...
11
Attitudes toward anticoagulant treatment among nonvalvular atrial fibrillation patients at high risk of stroke and low risk of bleed
... about treatment prefer- ences, patients most frequently agreed with statements indi- cating a high degree of trust in physicians and other health professionals as ...
11
Anticoagulant Treatment With Rivaroxaban in Severe Protein S Deficiency
... the anticoagulant function of activated protein ...bleeding, treatment with prothrombin complex concentrates or recombinant activated factor VII are the most plau- sible ...
7
Adherence to a new oral anticoagulant treatment prescription: dabigatran etexilate
... anticoagulation treatment, dabigatran etexilate, is already on the market in ...K anticoagulant (VKA) ...oral treatment, instead of the usual daily injection in major orthopedic surgery, is complex, ...
5
Towards improvement of oral anticoagulant therapy
... the anticoagulant proteins C and S. Although both pro- and anticoagulant proteins are no longer post-translationally modified to biological active proteins in the presence of warfarin, the net effect of ...
155
Noacs or warfarin after thrombolysis for the treatment of acute intermediate high riskpulmonary embolism: no war study
... been anticoagulant treatment with parenteral heparins and oral vitamin K ...the treatment of venous ...thromboembolism treatment, and provided significant reductions in major bleeding ...the ...
7
Considerations for long-term anticoagulant therapy in patients with venous thromboembolism in the novel oral anticoagulant era
... recurrent VTE include recent surgery and/or trauma, active cancer, advanced age, male sex, obesity, immobility, and thrombophilia. Some of these risk factors, such as surgery and immobility, may be reversible or ...
12
“Knowledge of, Satisfaction with and Adherence to Oral Anticoagulant Drugs among Patients in King Fasial Hospital; Taif, Kingdom of Saudi Arabia” by Dr. Abubaker Ibrahim Elbur, Dr. Ahmed Abdulrahman Albarraq, Dr. Mohammed M. Maugrabi, Sultan Abdullah Alharthi, Kingdom of Saudi Arabia.
... oral anticoagulant therapy was found to be ...oral anticoagulant treatment have many difficulties to maintain adequate adherence to treatment regimens, which may result in significant effects ...
7
Spontaneous Hemothorax Due to Oral Anticoagulant Therapy
... Oral anticoagulant treatment is widely used in many diseases, with warfarin being the most commonly used active ...the treatment, the patient developed a rare complication of spontaneous ...oral ...
5
Diet as prophylaxis and treatment for venous thromboembolism?
... with anticoagulant treatment [25] and prophylaxis ...with anticoagulant prophylaxis) × 35/28,419 (excess risk for fatal PE per Goldha- ber and Lindblad studies) = 14,779; 95% CI, 5,305 - ...
24
Anticoagulant Activity of Substituted Hydroxy Propoxycoumarin Derivatives
... to study pharmacological screening and synthetic aspects of the coumarin ring structure especially its combined analogues profile as an anticoagulant and antihypertensive property. Our first aim is to study ...
5
Electronic Counselling for Oral Anticoagulant Patients
... This new class of anticoagulants has been described using various terms: Novel oral anticoagulants or new oral anticoagulants (NOACs), non-vitamin K antagonist oral anticoagulants (NOACs), target-specific oral ...
210
Effects of computer-assisted oral anticoagulant therapy
... A computer-aided management system for telemedical oral anticoagulant therapy named CoaguTel was devel- oped and tested cooperatively by the IT-company Context and Frederiksberg Hospital (FH). This computer system ...
7
Treatment of venous thromboembolism – effects of different therapeutic strategies on bleeding and recurrence rates and considerations for future anticoagulant management
... To date, initial heparin followed by VKA has shown the greatest benefit in reducing the rate of recurrent VTE. This regimen therefore represents the current gold standard against which any new treatment will be ...
9
Anticoagulant Activity of Methylated Coumarin Derivatives
... Tremendous research on coumarin derivatives and anticoagulant drug are main inspiration of this work. Methylated coumarin derivative substituted by alkylaminohaydroxypropoxy side chain gives antihypertensive as ...
8